August 20, 2017 4:58 AM ET

Pharmaceuticals

Company Overview of Teva Pharmaceutical Industries Limited

Executive Profile

Yitzhak Peterburg M.D., Dr.P.H., MSc

Interim CEO, Interim President & Director, Teva Pharmaceutical Industries Limited
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships
66--

Background

Dr. Yitzhak Peterburg, M.D., Dr.P.H., MSc has been an Interim Chief Executive Officer and Interim President of Teva Pharmaceutical Industries Limited since February 6, 2017. Dr. Peterburg served as a Senior Vice President and Head of Global Branded Products at TEVA Pharmaceuticals from 2010 to 2011. Dr. Peterburg served as Vice President of Global Branded Products at Teva Pharmaceutical Industries Limited with responsibility for branded products, R&D, business development ...

Corporate Headquarters

5 Basel Street
Petach Tikva, -- 49131

Israel

Phone: 972 3 926 7267
Fax: 972 3 923 4050

Board Members Memberships

Chairman
2012-Present
Interim CEO, Interim President & Director

Education

Doctorate
Columbia University
MS
The London School of Economics and Political Science
MD 1977
Hebrew University Faculty of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Flemming Ornskov M.D., MBA, MPHCEO, MD & Executive Director
Shire plc
$4.3M
Feike Sijbesma Chairman of the Managing Board and Chief Executive Officer
Koninklijke DSM N.V.
$1.6M
Stefan Oschmann Chairman of Executive Board and Chief Executive Officer
Merck Kommanditgesellschaft auf Aktien
$4.5M
Robert J. MacLeod Chief Executive & Executive Director
Johnson Matthey Plc
$1.3M
Richard Ridinger Chief Executive Officer
Lonza Group Ltd
$2.8M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Teva Pharmaceutical Industries Limited, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.